203 related articles for article (PubMed ID: 28291627)
1. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Li J; Chen X; Dai M; Huang S; Chen J; Dai S
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627
[TBL] [Abstract][Full Text] [Related]
2. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C
PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.
Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D
Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
10. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
11. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
12. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
[TBL] [Abstract][Full Text] [Related]
13. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
[TBL] [Abstract][Full Text] [Related]
14. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.
Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L
Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170
[TBL] [Abstract][Full Text] [Related]
15. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
16. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Jia X; Liu J; Gao Y; Huang Y; Du Z
Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
19. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Sun T; Tang Y; Sun D; Bu Q; Li P
Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
